<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Ecuador_Notebook skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Ecuador/Notebook</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="ecuador_menu"><A href="https://2018.igem.org/Team:Ecuador"><DIV class="ecuador_home">
			iGEM ECUADOR
		  </DIV></A><DIV class="menu_options_container"><DIV id="project" class="menu_option"><A class="ecuador_href_text" href="https://2018.igem.org/Team:Ecuador/Description">
			PROJECT
			  </A><DIV class="menu_sub_options_container"><A class="ecuador_href_sub_text" href="https://2018.igem.org/Team:Ecuador/Description"><DIV class="sub_menu_option">
				  DESCRIPTION
				</DIV></A><A class="ecuador_href_sub_text" href="https://2018.igem.org/Team:Ecuador/Background"><DIV class="sub_menu_option">
				  BACKGROUND
				</DIV></A><A class="ecuador_href_sub_text" href="https://2018.igem.org/Team:Ecuador/Model"><DIV class="sub_menu_option">
				MODELING
			  </DIV></A><A class="ecuador_href_sub_text" href="https://2018.igem.org/Team:Ecuador/Design"><DIV class="sub_menu_option">
				  DESIGN
				</DIV></A><A class="ecuador_href_sub_text" href="https://2018.igem.org/Team:Ecuador/Experiments"><DIV class="sub_menu_option">
				  EXPERIMENTS
				</DIV></A><A class="ecuador_href_sub_text" href="https://2018.igem.org/Team:Ecuador/Notebook"><DIV class="sub_menu_option">
				  NOTEBOOK
				</DIV></A><A class="ecuador_href_sub_text" href="https://2018.igem.org/Team:Ecuador/Results"><DIV class="sub_menu_option">
				  RESULTS
				</DIV></A></DIV></DIV><DIV id="parts" class="menu_option"><A class="ecuador_href_text" href="https://2018.igem.org/Team:Ecuador/Parts">
				PARTS
				</A></DIV><DIV id="human_practice" class="menu_option"><A class="ecuador_href_text" href="https://2018.igem.org/Team:Ecuador/Human_Practices">
				HUMAN PRACTICES
			  </A><DIV class="menu_sub_options_container"><A class="ecuador_href_sub_text" href="https://2018.igem.org/Team:Ecuador/Human_Practices"><DIV class="sub_menu_option">
						HUMAN PRACTICES
				  </DIV></A><A class="ecuador_href_sub_text" href="https://2018.igem.org/Team:Ecuador/Public_Engagement"><DIV class="sub_menu_option">
						PUBLIC ENGAGEMENT
				  </DIV></A><A class="ecuador_href_sub_text" href="https://2018.igem.org/Team:Ecuador/Best-In-Human-Pract"><DIV class="sub_menu_option" style="font-size: 10px">
						BEST INTEGRADED HUMAN PRACTICES
				  </DIV></A></DIV></DIV><DIV id="safety" class="menu_option"><A class="ecuador_href_text" href="https://2018.igem.org/Team:Ecuador/Safety">
				SAFETY
				</A></DIV><DIV id="interlab" class="menu_option"><A class="ecuador_href_text" href="http://2018.iGEM.org/Team:Ecuador/Interlab">
			  INTERLAB
			</A></DIV><DIV id="judging_forms" class="menu_option"><A class="ecuador_href_text" href="http://2018.iGEM.org/Team:Ecuador/Judging">
			  JUDGING FORMS
			</A></DIV><DIV id="team" class="menu_option"><A class="ecuador_href_text" href="https://2018.igem.org/Team:Ecuador/Team">
			TEAM
			  </A><DIV class="menu_sub_options_container"><A class="ecuador_href_sub_text" href="https://2018.igem.org/Team:Ecuador/Team"><DIV class="sub_menu_option">
						TEAM MEMBERS
					</DIV></A><A class="ecuador_href_sub_text" href="https://2018.igem.org/Team:Ecuador/Collaborations"><DIV class="sub_menu_option" style="font-size: 13.5px">
					COLLABORATIONS
				  </DIV></A></DIV></DIV><DIV id="atributions" class="menu_option"><A class="ecuador_href_text" href="https://2018.igem.org/Team:Ecuador/Attributions">
				  ATTRIBUTIONS
			  </A><DIV class="menu_sub_options_container"><A class="ecuador_href_sub_text" href="https://2018.igem.org/Team:Ecuador/Attributions"><DIV class="sub_menu_option">
					ATRIBUTTIONS
				  </DIV></A><A class="ecuador_href_sub_text" href="https://2018.igem.org/Team:Ecuador/Sponsoring"><DIV class="sub_menu_option">
					SPONSORING
				  </DIV></A></DIV></DIV></DIV></DIV><DIV class="igem_2018_team_content"><DIV class="igem_2018_team_column_wrapper"><TITLE>C-lastin, Interlab</TITLE><DIV class="ec--modeling--container"><DIV class="ec--first--section"><DIV class="ec--main--title"><H1>
					NOTEBOOK
				</H1></DIV><DIV class="ec--modeling--items"><H3><A href="#INT" style="color:black; text-decoration: none">Index</A></H3><UL class="circle"><LI><A href="#l1" style="color:black; text-decoration: none">November2017</A></LI><LI><A href="#l2" style="color:black; text-decoration: none">December 2017</A></LI><LI><A href="#l3" style="color:black; text-decoration: none">January 2018</A></LI><LI><A href="#l4" style="color:black; text-decoration: none">February 2018</A></LI><LI><A href="#l5" style="color:black; text-decoration: none">March 2018</A></LI><LI><A href="#l6" style="color:black; text-decoration: none">April 2018</A></LI><LI><A href="#l7" style="color:black; text-decoration: none">May 2018</A></LI><LI><A href="#l8" style="color:black; text-decoration: none">June 2018</A></LI><LI><A href="#l9" style="color:black; text-decoration: none">July 2018</A></LI><LI><A href="#l10" style="color:black; text-decoration: none">August 2018</A></LI><LI><A href="#l11" style="color:black; text-decoration: none">September 2018</A></LI><LI><A href="#l12" style="color:black; text-decoration: none">October 2018</A></LI></UL></DIV></DIV><DIV class="ec--nau--content"><DIV class="WordSection1"><DIV align="center"><TABLE class="a" border="1" cellspacing="0" cellpadding="0" width="616" style="border-collapse:
 collapse;mso-table-layout-alt:fixed;border:none;mso-border-alt:dotted black 2.25pt;
 mso-yfti-tbllook:1024;mso-padding-alt:0in 5.4pt 0in 5.4pt;mso-border-insideh:
 .5pt dotted black;mso-border-insidev:2.25pt dotted black"><TBODY><TR style="mso-yfti-irow:0;mso-yfti-firstrow:yes"><TD width="52" style="width:39.25pt;border:dotted black 2.25pt;border-bottom:
  dotted black 1.0pt;mso-border-alt:dotted black 2.25pt;mso-border-bottom-alt:
  dotted black .5pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
  mso-fareast-font-family:Arial;color:#546421">Nov 17</SPAN></B></P></TD><TD width="52" style="width:38.85pt;border-top:dotted black 2.25pt;border-left:
  none;border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-alt:dotted black 2.25pt;
  mso-border-bottom-alt:dotted black .5pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
  mso-fareast-font-family:Arial;color:#387026">Dec 17</SPAN></B></P></TD><TD width="50" style="width:37.8pt;border-top:dotted black 2.25pt;border-left:
  none;border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-alt:dotted black 2.25pt;
  mso-border-bottom-alt:dotted black .5pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
  mso-fareast-font-family:Arial;color:#08674D">Jan</SPAN></B></P><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
  mso-fareast-font-family:Arial;color:#08674D">18</SPAN></B></P></TD><TD width="51" style="width:38.4pt;border-top:dotted black 2.25pt;border-left:
  none;border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-alt:dotted black 2.25pt;
  mso-border-bottom-alt:dotted black .5pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
  mso-fareast-font-family:Arial;color:#05686C">Feb</SPAN></B></P><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
  mso-fareast-font-family:Arial;color:#05686C">18</SPAN></B></P></TD><TD width="52" style="width:39.1pt;border-top:dotted black 2.25pt;border-left:
  none;border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-alt:dotted black 2.25pt;
  mso-border-bottom-alt:dotted black .5pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
  mso-fareast-font-family:Arial;color:#004E6C">Mar 18</SPAN></B></P></TD><TD width="52" style="width:38.8pt;border-top:dotted black 2.25pt;border-left:
  none;border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-alt:dotted black 2.25pt;
  mso-border-bottom-alt:dotted black .5pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
  mso-fareast-font-family:Arial;color:#073763">April 18</SPAN></B></P></TD><TD width="53" style="width:39.7pt;border-top:dotted black 2.25pt;border-left:
  none;border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-alt:dotted black 2.25pt;
  mso-border-bottom-alt:dotted black .5pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
  mso-fareast-font-family:Arial;color:#073763">May 18</SPAN></B></P></TD><TD width="53" style="width:39.7pt;border-top:dotted black 2.25pt;border-left:
  none;border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-alt:dotted black 2.25pt;
  mso-border-bottom-alt:dotted black .5pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
  mso-fareast-font-family:Arial;color:#004E6C">June 18</SPAN></B></P></TD><TD width="48" style="width:35.65pt;border-top:dotted black 2.25pt;border-left:
  none;border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-alt:dotted black 2.25pt;
  mso-border-bottom-alt:dotted black .5pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
  mso-fareast-font-family:Arial;color:#05686C">July 18</SPAN></B></P></TD><TD width="52" style="width:39.3pt;border-top:dotted black 2.25pt;border-left:
  none;border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-alt:dotted black 2.25pt;
  mso-border-bottom-alt:dotted black .5pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
  mso-fareast-font-family:Arial;color:#08674D">Aug 18</SPAN></B></P></TD><TD width="53" style="width:39.5pt;border-top:dotted black 2.25pt;border-left:
  none;border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-alt:dotted black 2.25pt;
  mso-border-bottom-alt:dotted black .5pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
  mso-fareast-font-family:Arial;color:#387026">Sept 18</SPAN></B></P></TD><TD width="48" style="width:36.05pt;border-top:dotted black 2.25pt;border-left:
  none;border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-alt:dotted black 2.25pt;
  mso-border-bottom-alt:dotted black .5pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
  mso-fareast-font-family:Arial;color:#546421">Oct 18</SPAN></B></P></TD></TR><TR style="mso-yfti-irow:1"><TD width="52" style="width:39.25pt;border-top:none;border-left:dotted black 2.25pt;
  border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:
  dotted black .5pt;mso-border-top-alt:.5pt;mso-border-left-alt:2.25pt;
  mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#7D9532">1</SPAN></P></TD><TD width="52" style="width:38.85pt;border-top:none;border-left:none;
  border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:
  dotted black .5pt;mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:
  .5pt;mso-border-left-alt:2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:
  2.25pt;mso-border-color-alt:black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#54A738">6</SPAN></P></TD><TD width="50" style="width:37.8pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0B9B74">10</SPAN></P></TD><TD width="51" style="width:38.4pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#089BA2">15</SPAN></P></TD><TD width="52" style="width:39.1pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0075A2">19</SPAN></P></TD><TD width="52" style="width:38.8pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#073763">23</SPAN></P></TD><TD width="53" style="width:39.7pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0B5394">27</SPAN></P></TD><TD width="53" style="width:39.7pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0075A2">31</SPAN></P></TD><TD width="48" style="width:35.65pt;border-top:none;border-left:none;
  border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:
  dotted black .5pt;mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:
  .5pt;mso-border-left-alt:2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:
  2.25pt;mso-border-color-alt:black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#089BA2">35</SPAN></P></TD><TD width="52" style="width:39.3pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0B9B74">39</SPAN></P></TD><TD width="53" style="width:39.5pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#54A738">44</SPAN></P></TD><TD width="48" style="width:36.05pt;border-top:none;border-left:none;
  border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:
  dotted black .5pt;mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:
  .5pt;mso-border-left-alt:2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:
  2.25pt;mso-border-color-alt:black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#7D9532">48</SPAN></P></TD></TR><TR style="mso-yfti-irow:2"><TD width="52" style="width:39.25pt;border-top:none;border-left:dotted black 2.25pt;
  border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:
  dotted black .5pt;mso-border-top-alt:.5pt;mso-border-left-alt:2.25pt;
  mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#7D9532">2</SPAN></P></TD><TD width="52" style="width:38.85pt;border-top:none;border-left:none;
  border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:
  dotted black .5pt;mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:
  .5pt;mso-border-left-alt:2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:
  2.25pt;mso-border-color-alt:black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#54A738">7</SPAN></P></TD><TD width="50" style="width:37.8pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0B9B74">11</SPAN></P></TD><TD width="51" style="width:38.4pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#089BA2">16</SPAN></P></TD><TD width="52" style="width:39.1pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0075A2">20</SPAN></P></TD><TD width="52" style="width:38.8pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#073763">24</SPAN></P></TD><TD width="53" style="width:39.7pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0B5394">28</SPAN></P></TD><TD width="53" style="width:39.7pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0075A2">32</SPAN></P></TD><TD width="48" style="width:35.65pt;border-top:none;border-left:none;
  border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:
  dotted black .5pt;mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:
  .5pt;mso-border-left-alt:2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:
  2.25pt;mso-border-color-alt:black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#089BA2">36</SPAN></P></TD><TD width="52" style="width:39.3pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0B9B74">40</SPAN></P></TD><TD width="53" style="width:39.5pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#54A738">45</SPAN></P></TD><TD width="48" style="width:36.05pt;border-top:none;border-left:none;
  border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:
  dotted black .5pt;mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:
  .5pt;mso-border-left-alt:2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:
  2.25pt;mso-border-color-alt:black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#7D9532">49</SPAN></P></TD></TR><TR style="mso-yfti-irow:3"><TD width="52" style="width:39.25pt;border-top:none;border-left:dotted black 2.25pt;
  border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:
  dotted black .5pt;mso-border-top-alt:.5pt;mso-border-left-alt:2.25pt;
  mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#7D9532">3</SPAN></P></TD><TD width="52" style="width:38.85pt;border-top:none;border-left:none;
  border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:
  dotted black .5pt;mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:
  .5pt;mso-border-left-alt:2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:
  2.25pt;mso-border-color-alt:black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#54A738">8</SPAN></P></TD><TD width="50" style="width:37.8pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0B9B74">12</SPAN></P></TD><TD width="51" style="width:38.4pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#089BA2">17</SPAN></P></TD><TD width="52" style="width:39.1pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0075A2">21</SPAN></P></TD><TD width="52" style="width:38.8pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#073763">25</SPAN></P></TD><TD width="53" style="width:39.7pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0B5394">29</SPAN></P></TD><TD width="53" style="width:39.7pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0075A2">33</SPAN></P></TD><TD width="48" style="width:35.65pt;border-top:none;border-left:none;
  border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:
  dotted black .5pt;mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:
  .5pt;mso-border-left-alt:2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:
  2.25pt;mso-border-color-alt:black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#089BA2">37</SPAN></P></TD><TD width="52" style="width:39.3pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0B9B74">41</SPAN></P></TD><TD width="53" style="width:39.5pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#54A738">46</SPAN></P></TD><TD width="48" style="width:36.05pt;border-top:none;border-left:none;
  border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:
  dotted black .5pt;mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:
  .5pt;mso-border-left-alt:2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:
  2.25pt;mso-border-color-alt:black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#7D9532">50</SPAN></P></TD></TR><TR style="mso-yfti-irow:4"><TD width="52" style="width:39.25pt;border-top:none;border-left:dotted black 2.25pt;
  border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:
  dotted black .5pt;mso-border-top-alt:.5pt;mso-border-left-alt:2.25pt;
  mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#7D9532">4</SPAN></P></TD><TD width="52" style="width:38.85pt;border-top:none;border-left:none;
  border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:
  dotted black .5pt;mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:
  .5pt;mso-border-left-alt:2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:
  2.25pt;mso-border-color-alt:black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#54A738">9</SPAN></P></TD><TD width="50" style="width:37.8pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0B9B74">13</SPAN></P></TD><TD width="51" style="width:38.4pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#089BA2">18</SPAN></P></TD><TD width="52" style="width:39.1pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0075A2">22</SPAN></P></TD><TD width="52" style="width:38.8pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#073763">26</SPAN></P></TD><TD width="53" style="width:39.7pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0B5394">30</SPAN></P></TD><TD width="53" style="width:39.7pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0075A2">34</SPAN></P></TD><TD width="48" style="width:35.65pt;border-top:none;border-left:none;
  border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:
  dotted black .5pt;mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:
  .5pt;mso-border-left-alt:2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:
  2.25pt;mso-border-color-alt:black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#089BA2">38</SPAN></P></TD><TD width="52" style="width:39.3pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0B9B74">42</SPAN></P></TD><TD width="53" style="width:39.5pt;border-top:none;border-left:none;border-bottom:
  dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:.5pt;mso-border-left-alt:
  2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:2.25pt;mso-border-color-alt:
  black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#54A738">47</SPAN></P></TD><TD width="48" style="width:36.05pt;border-top:none;border-left:none;
  border-bottom:dotted black 1.0pt;border-right:dotted black 2.25pt;mso-border-top-alt:
  dotted black .5pt;mso-border-left-alt:dotted black 2.25pt;mso-border-top-alt:
  .5pt;mso-border-left-alt:2.25pt;mso-border-bottom-alt:.5pt;mso-border-right-alt:
  2.25pt;mso-border-color-alt:black;mso-border-style-alt:dotted;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#7D9532">51</SPAN></P></TD></TR><TR style="mso-yfti-irow:5;mso-yfti-lastrow:yes"><TD width="52" style="width:39.25pt;border:dotted black 2.25pt;border-top:none;
  mso-border-top-alt:dotted black .5pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#7D9532">5</SPAN></P></TD><TD width="52" style="width:38.85pt;border-top:none;border-left:none;
  border-bottom:dotted black 2.25pt;border-right:dotted black 2.25pt;
  mso-border-top-alt:dotted black .5pt;mso-border-left-alt:dotted black 2.25pt;
  padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#54A738"><O:P> </O:P></SPAN></P></TD><TD width="50" style="width:37.8pt;border-top:none;border-left:none;border-bottom:
  dotted black 2.25pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0B9B74">14</SPAN></P></TD><TD width="51" style="width:38.4pt;border-top:none;border-left:none;border-bottom:
  dotted black 2.25pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#089BA2"><O:P> </O:P></SPAN></P></TD><TD width="52" style="width:39.1pt;border-top:none;border-left:none;border-bottom:
  dotted black 2.25pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0075A2"><O:P> </O:P></SPAN></P></TD><TD width="52" style="width:38.8pt;border-top:none;border-left:none;border-bottom:
  dotted black 2.25pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#073763"><O:P> </O:P></SPAN></P></TD><TD width="53" style="width:39.7pt;border-top:none;border-left:none;border-bottom:
  dotted black 2.25pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0B5394"><O:P> </O:P></SPAN></P></TD><TD width="53" style="width:39.7pt;border-top:none;border-left:none;border-bottom:
  dotted black 2.25pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0075A2"><O:P> </O:P></SPAN></P></TD><TD width="48" style="width:35.65pt;border-top:none;border-left:none;
  border-bottom:dotted black 2.25pt;border-right:dotted black 2.25pt;
  mso-border-top-alt:dotted black .5pt;mso-border-left-alt:dotted black 2.25pt;
  padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#089BA2"><O:P> </O:P></SPAN></P></TD><TD width="52" style="width:39.3pt;border-top:none;border-left:none;border-bottom:
  dotted black 2.25pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#0B9B74">43</SPAN></P></TD><TD width="53" style="width:39.5pt;border-top:none;border-left:none;border-bottom:
  dotted black 2.25pt;border-right:dotted black 2.25pt;mso-border-top-alt:dotted black .5pt;
  mso-border-left-alt:dotted black 2.25pt;padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#54A738"><O:P> </O:P></SPAN></P></TD><TD width="48" style="width:36.05pt;border-top:none;border-left:none;
  border-bottom:dotted black 2.25pt;border-right:dotted black 2.25pt;
  mso-border-top-alt:dotted black .5pt;mso-border-left-alt:dotted black 2.25pt;
  padding:0in 5.4pt 0in 5.4pt"><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;
  line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
  color:#7D9532"><O:P> </O:P></SPAN></P></TD></TR></TBODY></TABLE></DIV><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
	line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">November
2017</SPAN></B></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Training in the principles of synthetic biology
course in edX. <B style="mso-bidi-font-weight:normal">Participation:</B>
Everyone</SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">December
2017</SPAN></B></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Training in the principles of synthetic biology
course in edX. <B style="mso-bidi-font-weight:normal">Participation:</B>
Everyone</SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">January
2018</SPAN></B></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Training in the principles of synthetic biology
course in edX. <B style="mso-bidi-font-weight:normal">Participation:</B>
Everyone</SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">February
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 16</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Participation and collaboration in the
introduction workshop to synthetic biology dictated by Heber Torres in
Universidad de las <SPAN class="SpellE">Fuerzas</SPAN> Armadas ESPE. <B style="mso-bidi-font-weight:normal">Participation:</B> Everyone</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">February
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 17</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l5 level1 lfo1;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Meeting to choose the project that will participate in <SPAN class="SpellE">iGEM</SPAN> 2018. <B style="mso-bidi-font-weight:normal">Participation:</B>
Everyone</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Brainstorm project ideas about synthetic biology</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">PROJECTS:</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l0 level1 lfo2;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Times New Roman&quot;,serif;
mso-fareast-font-family:&quot;Times New Roman&quot;;color:black"><SPAN style="mso-list:
Ignore">-<SPAN style="font:7.0pt &quot;Times New Roman&quot;">       </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Spider silk production in yeast </SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l0 level1 lfo2;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Times New Roman&quot;,serif;
mso-fareast-font-family:&quot;Times New Roman&quot;;color:black"><SPAN style="mso-list:
Ignore">-<SPAN style="font:7.0pt &quot;Times New Roman&quot;">       </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Production of ivory in yeasts to reduce the furtive hunting by
this material</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l0 level1 lfo2;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Times New Roman&quot;,serif;
mso-fareast-font-family:&quot;Times New Roman&quot;;color:#0F6FC6"><SPAN style="mso-list:Ignore">-<SPAN style="font:7.0pt &quot;Times New Roman&quot;">       </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Production of colicine in <I style="mso-bidi-font-style:normal">Saccharomyces
<SPAN class="SpellE">boulardii</SPAN></I> to use it as <SPAN class="GramE">a
probiotic antibacterial infections</SPAN></SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l0 level1 lfo2;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Times New Roman&quot;,serif;
mso-fareast-font-family:&quot;Times New Roman&quot;;color:#0F6FC6"><SPAN style="mso-list:Ignore">-<SPAN style="font:7.0pt &quot;Times New Roman&quot;">       </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Recombinant production of fusion proteins and their coupling to
bacterial cellulose for obtaining a biomaterial.</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">February
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 18</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l5 level1 lfo1;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Meeting to decide the winning project. <B style="mso-bidi-font-weight:
normal">Participation:</B> Everyone</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">The winning project was: <B style="mso-bidi-font-weight:
normal">“Recombinant production of fusion proteins and their coupling to
bacterial cellulose for obtaining a biomaterial”</B></SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">March
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 19</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Meeting with two researchers with experience in
synthetic biology and <SPAN class="SpellE">Igem</SPAN> competitions and they help
us to delimit the project. <B style="mso-bidi-font-weight:normal">Participation:</B>
Everyone</SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">March
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 20</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">In this week, we designed the logo and the name
of our project. <B style="mso-bidi-font-weight:normal">Participation:</B>
Everyone</SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">THE WINNER!!!</SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">March
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 21</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l5 level1 lfo1;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Looking for sponsoring with Ecuadorian enterprises but we only get
the sponsorship of two: <SPAN class="SpellE">IDgen</SPAN> and <SPAN class="SpellE">Tuki</SPAN>.
<B style="mso-bidi-font-weight:normal">Participation:</B><SPAN class="SpellE">Estefany</SPAN>
Paredes and Camila <SPAN class="SpellE">Velandia</SPAN></SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Dragon <SPAN class="SpellE">Tatoo</SPAN>!!</SPAN></B></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l5 level1 lfo1;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">We decided to make a raffle to raise funds for the registration in
<SPAN class="SpellE">iGEM</SPAN> 2018. <B style="mso-bidi-font-weight:normal">Participation:</B>
Everyone</SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">March
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 22</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">In this week the winners of the raffle were awarded. <B style="mso-bidi-font-weight:normal">Participation:</B> Everyone</SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">We also chose the design of our shirts. <B style="mso-bidi-font-weight:
normal">Participation:</B> Everyone</SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Inscription in <SPAN class="SpellE">Igem</SPAN> 2018 with funds
obtained</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></B></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">April
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 23</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Videoconference with Heber Torres to elucidate
the best methods to follow for the development of the project. <B style="mso-bidi-font-weight:normal">Participation:</B> Everyone</SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">April
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 24</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Videoconference with the Tec de Monterrey to
discuss our project. <B style="mso-bidi-font-weight:normal">Participation:</B><SPAN class="SpellE">Estefany</SPAN> Paredes, Camila <SPAN class="SpellE">Velandia</SPAN>,
Jennifer Tapia, Nicolas Lopez.</SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">April
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 25</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Interview with channel “<SPAN class="SpellE">Teleamazonas</SPAN>”
to spread the synthetic biology. <B style="mso-bidi-font-weight:normal">Participation:</B>
Everyone</SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">April
	- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 26</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Participation in the mathematical modeling course dictated by
delft university of technology in edX platform. </SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Participation in dynamical modeling methods for systems biology in
Coursera platform, dictated by Icahn school of medicine at Mount Sinai. <B style="mso-bidi-font-weight:normal">Participation:</B><SPAN class="SpellE">Estefany</SPAN>
Paredes in collaboration with Francisco <SPAN class="SpellE">Mosquera</SPAN>.</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">May
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 27</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">This week we dedicated ourselves completely to
finish the two online courses we were doing. <B style="mso-bidi-font-weight:
normal">Participation:</B><SPAN class="SpellE">Estefany</SPAN> Paredes in
collaboration with Francisco <SPAN class="SpellE">Mosquera</SPAN>.</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">May
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 28</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Review of topics learned in online courses and
search parameters. <B style="mso-bidi-font-weight:normal">Participation: </B>Everyone</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">May
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 29</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l6 level1 lfo3;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Start of sequence design </SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l6 level1 lfo3;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Sequence design for cellulose production. <B style="mso-bidi-font-weight:
normal">Participation: </B>Everyone</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">May
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 30</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Sequence design <SPAN class="GramE">for the
production of</SPAN> fusion proteins. <B style="mso-bidi-font-weight:normal">Participation:
</B>Everyone</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">June
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 31</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">We dedicate this week to the search of
parameters for a modeling. <B style="mso-bidi-font-weight:normal">Participation:
</B>Everyone</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">June
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 32</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Meeting with the Ministry of Environment for
construction of the country position in synthetic biology, digital sequences
and risk assessment and management guides for GMO. <B style="mso-bidi-font-weight:
normal">Participation: </B>Nicolas Lopez in collaboration with Francisco <SPAN class="SpellE">Mosquera</SPAN>.</SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US"><O:P> </O:P></SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">June
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 33</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l2 level1 lfo4;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Start of the <SPAN class="SpellE"><B style="mso-bidi-font-weight:
normal">Interlab</B></SPAN>. Searching the plate reader with absorbance and
fluorescence in <SPAN class="GramE">others</SPAN> universities of Ecuador.
Biomedicine team of University &quot;UTE&quot; let us use their equipment,
where Linda <SPAN class="SpellE">Guaman</SPAN>, our instructor, works. <B style="mso-bidi-font-weight:normal">Participation:</B> Natalia Torres in
collaboration with PI’s and Instructors.</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l2 level1 lfo4;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Video conferencing with the Estonia <SPAN class="SpellE">iGem</SPAN>
team</SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US"><O:P> </O:P></SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">June
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 34</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l7 level1 lfo6;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN class="SpellE"><B style="mso-bidi-font-weight:
normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:
&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;color:black">Interlab</SPAN></B></SPAN><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">:</SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:
150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;color:black">
Preparation of materials, LB broth and agar plates with chloramphenicol (25 </SPAN><SPAN lang="EN-US" style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;color:black">ì</SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">L/mL), SOC media, SOB agar, CCMB80 Buffer. <B style="mso-bidi-font-weight:
normal">Participation:</B> Natalia Torres and Jennifer Tapia</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Realization of modeling. <B style="mso-bidi-font-weight:normal">Participation:</B><SPAN class="SpellE">Estefany</SPAN> Paredes in collaboration with Francisco <SPAN class="SpellE">Mosquera</SPAN>.</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">July
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 35</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Meeting up <SPAN class="SpellE">Latinoamérica</SPAN></SPAN></P><P class="MsoNormal" align="center" style="margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:.5in;margin-bottom:.0001pt;text-align:center;
text-indent:-.5in;line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"> </P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US"><O:P> </O:P></SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN class="SpellE"><B style="mso-bidi-font-weight:
normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:
&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;color:black">Interlab</SPAN></B></SPAN><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">:</SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:
150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;color:black">
Preparation of stock solutions, application and measurement of calibration
protocols. <B style="mso-bidi-font-weight:normal">Participation:</B> Natalia
Torres, Juan Carlos <SPAN class="SpellE">Luzuriaga</SPAN> in collaboration with
Eduardo <SPAN class="SpellE">Moncayo</SPAN>.</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">July
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 36</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Application in the national unpublished financing program</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN class="SpellE"><B style="mso-bidi-font-weight:
normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:
&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;color:black">Interlab</SPAN></B></SPAN><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">:</SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:
150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;color:black">
Application of competent cells protocol and practice transformation protocol of
<SPAN class="SpellE">iGEM</SPAN>. In the photo, you can see a control of the
transformation protocol with RFP. <B style="mso-bidi-font-weight:normal">Participation:</B>
Juan Carlos <SPAN class="SpellE">Luzuriaga</SPAN> and Jennifer Tapia in
collaboration with Eduardo <SPAN class="SpellE">Moncayo</SPAN>.</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">July
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 37</SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN class="SpellE"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Interlab</SPAN></B></SPAN><B style="mso-bidi-font-weight:
normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:
&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">:</SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial"> Transformation with the <SPAN class="SpellE">BioBricks</SPAN>
and measurement of fluorescent cells. In the photo, you can see the laboratory
of Biomedicine team in the University &quot;UTE&quot;. <B style="mso-bidi-font-weight:
normal">Participation:</B> Jennifer Tapia, Juan Carlos <SPAN class="SpellE">Luzuriaga</SPAN>
and Natalia Torres in collaboration with Eduardo <SPAN class="SpellE">Moncayo</SPAN>.</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">July
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 38</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN class="SpellE"><B style="mso-bidi-font-weight:
normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:
&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;color:black">Interlab</SPAN></B></SPAN><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">:</SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:
150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;color:black">
Repetition of transformation with the <SPAN class="SpellE">BioBricks</SPAN> and
measurement of cells. Application of Protocol: Colony Forming Units per 0.1
OD-- E. coli cultures. Sending of raw data and forms. <B style="mso-bidi-font-weight:
normal">Participation:</B> Jennifer Tapia, Juan Carlos <SPAN class="SpellE">Luzuriaga</SPAN>
and Natalia Torres in collaboration with Eduardo <SPAN class="SpellE">Moncayo</SPAN>.</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Conducted talks on the importance of synthetic biology in the
world and prospective in the country, this talk was held in 4 schools in Quito:
<SPAN class="SpellE">Colegio</SPAN> de Liga, <SPAN class="SpellE">Liceo</SPAN><SPAN class="SpellE"><SPAN class="GramE">policial</SPAN></SPAN><SPAN class="GramE">,Émile</SPAN><SPAN class="SpellE">Jaques</SPAN><SPAN class="SpellE">Dalcroze</SPAN>, <SPAN class="SpellE">Ángel</SPAN><SPAN class="SpellE">Polibio</SPAN> Chávez. <B style="mso-bidi-font-weight:normal">Participation:</B>
Everyone.</SPAN></P><P class="MsoNormal" align="center" style="margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:.5in;margin-bottom:.0001pt;text-align:center;
text-indent:-.5in;line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US"><O:P> </O:P></SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US"><O:P> </O:P></SPAN></P><P class="MsoNormal" align="center" style="margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:.5in;margin-bottom:.0001pt;text-align:center;
text-indent:-.5in;line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US"><O:P> </O:P></SPAN></P><P class="MsoNormal" align="center" style="margin-left:.5in;text-align:center;
text-indent:-.5in;line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"> </P><P class="MsoNormal" style="margin-left:.5in;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:
150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">August</SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial"> - Week 39</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l4 level1 lfo7;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Competent cells preparation</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN class="SpellE"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black">Células</SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black"> E. coli DH5α, BL21(DE3) y
BL21(DE3) <SPAN class="SpellE">pLyss</SPAN> were prepared using the CaCl2 method,
modifying slightly the one described in: </SPAN><SPAN lang="EN-US"><A href="http://parts.igem.org/Help:Protocols/Competent_Cells"><SPAN style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:#F49100">http://parts.igem.org/Help:Protocols/Competent_Cells</SPAN></A></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black">. <B style="mso-bidi-font-weight:
normal">Participation:</B><SPAN class="SpellE">Estefany</SPAN> Paredes in
collaboration with Francisco <SPAN class="SpellE">Mosquera</SPAN>.</SPAN></P><P class="MsoNormal" align="center" style="margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:.5in;margin-bottom:.0001pt;text-align:center;
text-indent:-.5in;line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="background:aqua;mso-highlight:
aqua"><O:P> </O:P></SPAN></P><P class="MsoNormal" align="center" style="margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:.5in;margin-bottom:.0001pt;text-align:center;
text-indent:-.5in;line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"> </P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:
150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l4 level1 lfo7;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN class="SpellE"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black">Resuspention</SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black"> of <SPAN class="SpellE">gBlocks</SPAN>:
<SPAN class="SpellE">bscA</SPAN>, <SPAN class="SpellE">bscB</SPAN>, bscC1, bscC2, <SPAN class="SpellE">bscD</SPAN>, <SPAN class="SpellE">bsCcPax</SPAN> and <SPAN class="SpellE">bsCmCax</SPAN>; with 20μl dH20, to reach a concentration of
50 ng/</SPAN><SPAN lang="EN-US" style="font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol;color:black">ì</SPAN><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black">L. <B style="mso-bidi-font-weight:
normal">Participation:</B> Camila <SPAN class="SpellE">Velandia</SPAN></SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l4 level1 lfo7;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Domestication with overhang PCR of <SPAN class="SpellE">bscA</SPAN>,
<SPAN class="SpellE">bscB</SPAN>, bscC1, bscC2 and <SPAN class="SpellE">bscD</SPAN>.
</SPAN></P><P class="MsoNormal" align="center" style="margin-left:35.4pt;text-align:center;
line-height:150%"> </P><P class="MsoNormal" style="margin-left:35.4pt;text-align:justify;line-height:
150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:
&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">In the electrophoresis gel
(1% agarose) with 1 kb DNA ladder (Lane 1), we obtained expected bands of <SPAN class="SpellE">bscA</SPAN> (Lane 2 - 2536 <SPAN class="SpellE">bp</SPAN>), <SPAN class="SpellE">bscB</SPAN> (Lane 3 - 2827 <SPAN class="SpellE">bp</SPAN>) and bscC2
(Lane 5 - 2139 <SPAN class="SpellE">bp</SPAN>); and unspecified bands of bscC1
(Lane 4) and <SPAN class="SpellE">bscD</SPAN> (Lane 6). <B style="mso-bidi-font-weight:
normal">Participation:</B> Juan Carlos <SPAN class="SpellE">Luzuriaga</SPAN> in
collaboration with Eduardo <SPAN class="SpellE">Moncayo</SPAN>.</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">August</SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial"> - Week 40</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l3 level1 lfo8;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN class="SpellE"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black">Linealization</SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black"> of the psb1C3 and psb1A3 plasmids
with PCR, using 8% DMSO. Amplification of <SPAN class="SpellE">LacI</SPAN> from
the commercial plasmid pET-24a-ELP[V-150] (<SPAN class="SpellE">Addgene</SPAN>). </SPAN></P><P class="MsoNormal" align="center" style="margin-left:35.4pt;text-align:center;
line-height:150%"> </P><P class="MsoNormal" style="margin-left:35.4pt;text-align:justify;line-height:
150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:
&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">In the electrophoresis gel
(1% agarose) with 1 kb DNA ladder (Lane 1), we obtained expected bands of
psb1C3 plasmid (Lane 2), psb1A3 plasmids (Lane 3) and <SPAN class="SpellE">LacI</SPAN>
(Lane 4 - 1420 <SPAN class="SpellE">bp</SPAN>). <B style="mso-bidi-font-weight:
normal">Participation:</B> Jennifer Tapia in collaboration with Eduardo <SPAN class="SpellE">Moncayo</SPAN>.</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l3 level1 lfo8;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black">Domestication of the <SPAN class="SpellE">gBlocks</SPAN> (CBD <SPAN class="SpellE">cipA</SPAN>, BMP2, <SPAN class="SpellE">sfGFP</SPAN>)</SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">. With the objective that the restriction enzymes <SPAN class="SpellE">EcoRI</SPAN> and <SPAN class="SpellE">PstI</SPAN> can cut <SPAN class="SpellE">gBlocks</SPAN> forming cohesive ends, we perform a PCR to add
their recognition sites. But in the design, we did not know that there should
be base pairs that flanked a restriction site, therefore, the first test
failed, but with the proper investigation we discovered this observation, then
sent to request primers to add those bases in prefix and <SPAN class="SpellE">subfix</SPAN>.</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">In this week, we also collaborated with the TEC CEM team
participating in a musical video about <SPAN class="SpellE">igem</SPAN>. Link: </SPAN><SPAN lang="EN-US"><A href="https://youtu.be/R7vdiGLLJZA?t=319"><SPAN style="font-size:
12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
Arial;color:#F49100">https://youtu.be/R7vdiGLLJZA?t=319</SPAN></A></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black">. <B style="mso-bidi-font-weight:
normal">Participation:</B><SPAN class="SpellE">Estefany</SPAN> Paredes in
collaboration with Francisco <SPAN class="SpellE">Mosquera</SPAN>.</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></B></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">August
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 41</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Domestication with overhang PCR of <SPAN class="SpellE">bscD</SPAN>
and <SPAN class="SpellE">LacI</SPAN>. </SPAN></P><P class="MsoNormal" align="center" style="margin-left:35.4pt;text-align:center;
line-height:150%"> </P><P class="MsoNormal" style="margin-left:35.4pt;text-align:justify;line-height:
150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:
&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">In the electrophoresis gel
(1% agarose) with 1 kb DNA ladder (Lane 1), we obtained unspecific bands (Lane
2) and expected bands of <SPAN class="SpellE">bscD</SPAN> (Lane 3 and 4 - 854 <SPAN class="SpellE">bp</SPAN>) with an unspecific band, and <SPAN class="SpellE">LacI</SPAN>
(Lane 5, 6 and 7 - 1420 <SPAN class="SpellE">bp</SPAN>). <B style="mso-bidi-font-weight:
normal">Participation:</B> Juan Carlos <SPAN class="SpellE">Luzuriaga</SPAN> in
collaboration with Eduardo <SPAN class="SpellE">Moncayo</SPAN>.</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">This week came the primers that we <SPAN class="GramE">ordered</SPAN>
and we amplified and purification the <SPAN class="SpellE">gBlocks</SPAN>: CBD <SPAN class="SpellE">cipA</SPAN> under the control of the promoter <SPAN class="SpellE">LacI</SPAN>,
BMP2 and <SPAN class="SpellE">sfGFP</SPAN>. <B style="mso-bidi-font-weight:normal">Participation:</B><SPAN class="SpellE">Estefany</SPAN> Paredes in collaboration with Francisco <SPAN class="SpellE">Mosquera</SPAN>.</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;mso-ansi-language:ES">NOTES:</SPAN></B></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%"><SPAN style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;mso-ansi-language:
ES">Gel de agarosa al 1% </SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">1X
TAE Buffer</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Lane
1: 1kb DNA ladder</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Lane
2: PCR product of BMP2 <SPAN class="SpellE">gBlock</SPAN> (541 <SPAN class="SpellE">bp</SPAN>)</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Lane
3: PCR product of CBD <SPAN class="SpellE">cipA</SPAN><SPAN class="SpellE">gBlock</SPAN>
(806 <SPAN class="SpellE">bp</SPAN>)</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Lane
4: PCR product of <SPAN class="SpellE">sfGFP</SPAN><SPAN class="SpellE">gBlock</SPAN>
(928 <SPAN class="SpellE">bp</SPAN>)</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></P><P class="MsoNormal" align="center" style="margin-left:35.4pt;text-align:center;
line-height:150%"> </P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%;
tab-stops:153.0pt"><SPAN style="font-size:10.5pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
mso-ansi-language:ES">NOTES:</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%"><SPAN style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;mso-ansi-language:
ES">Gel de agarosa al 1% </SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">1X
TAE Buffer</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Lane
1: 1kb DNA ladder</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Lane
2-5: PCR products of elastin-like polypeptide V150.</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Lane
6: Purified PCR product of CBD <SPAN class="SpellE">cipA</SPAN><SPAN class="SpellE">gBlock</SPAN></SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Lane
7: Purified PCR product of BMP2 <SPAN class="SpellE">gBlock</SPAN></SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Lane
8: Purified PCR product of <SPAN class="SpellE">sfGFP</SPAN><SPAN class="SpellE">gBlock</SPAN></SPAN></P><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify;line-height:150%"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">We decided to carry out a molecular techniques course <SPAN class="GramE">in order to</SPAN> disseminate synthetic biology tools. <B style="mso-bidi-font-weight:normal">Participation:</B> Everyone</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US"><O:P> </O:P></SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">August
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 42</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;tab-stops:153.0pt;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-family:&quot;Noto Sans Symbols&quot;;mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;
mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;color:black"><SPAN style="mso-list:
Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">      </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black">Transformation (on the left CBD
cipA-BMP2 and to the right is the <SPAN class="SpellE">CBD_sfGFP</SPAN>) </SPAN><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Participation:</SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black"><SPAN class="SpellE">Estefany</SPAN> Paredes in collaboration with
Francisco <SPAN class="SpellE">Mosquera</SPAN>.</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;tab-stops:153.0pt;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black"><O:P> </O:P></SPAN></P><P class="MsoNormal" align="center" style="margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:.5in;margin-bottom:.0001pt;text-align:center;
text-indent:-.5in;line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US"><O:P> </O:P></SPAN></P><P class="MsoNormal" align="center" style="margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:.5in;margin-bottom:.0001pt;text-align:center;
text-indent:-.5in;line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"> </P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:
150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;tab-stops:153.0pt;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Construction of the composite part <SPAN class="SpellE">cbd</SPAN><SPAN class="SpellE">cipA</SPAN>-ELP. We obtained expect brands of PCR ELP <SPAN class="GramE">productfrom</SPAN>
pET-24a-ELP[V-150] using the primers Forward 1 y Reverse1 with 509 <SPAN class="SpellE">pb</SPAN>. <B style="mso-bidi-font-weight:normal">Participation:</B><SPAN class="SpellE">Estefany</SPAN> Paredes in collaboration with Francisco <SPAN class="SpellE">Mosquera</SPAN>.</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;tab-stops:153.0pt;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:
150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;color:black"><O:P> </O:P></SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US"><O:P> </O:P></SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black">Notes:</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black">Lane 1: 100 <SPAN class="SpellE">pb</SPAN>
DNA ladder</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black">Lane 2: PCR ELP <SPAN class="GramE">productfrom</SPAN> pET-24a-ELP[V-150] using the
primers Forward 1 y Reverse1</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black">Lane 3: PCR ELP <SPAN class="GramE">productfrom</SPAN> pET-24a-ELP[V-150] using the
primers Forward 1 y Reverse3</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black">Lane 3: PCR ELP <SPAN class="GramE">productfrom</SPAN> pET-24a-ELP[V-150] using the
primers Forward 1 y Reverse2</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:
150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;color:black"><O:P> </O:P></SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Domestication with overhang PCR of bscC1. </SPAN></P><P class="MsoNormal" align="center" style="margin-left:35.4pt;text-align:center;
line-height:150%"> </P><P class="MsoNormal" style="margin-left:35.4pt;text-align:justify;line-height:
150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:
&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">In the electrophoresis gel
(1% agarose) with 1 kb DNA ladder (Lane A), we obtained an expected band of
bscC1 (Lane B - 2152 <SPAN class="SpellE">bp</SPAN>) with two unspecific bands. <B style="mso-bidi-font-weight:normal">Participation:</B> Nicolas Lopez</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">August
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 43</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">We obtained a similar pattern of bands, 500 <SPAN class="SpellE">bp</SPAN>,
this is because it is a repetitive <SPAN class="GramE">sequence</SPAN> so we
decided to purify the fragment obtained and then sequence it. <B style="mso-bidi-font-weight:normal">Participation:</B><SPAN class="SpellE">Estefany</SPAN>
Paredes in collaboration with Francisco <SPAN class="SpellE">Mosquera</SPAN>.</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:
150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;color:black"><O:P> </O:P></SPAN></P><P class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify;line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
Arial;color:black;mso-ansi-language:ES">NOTES:</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN style="font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:
Arial;color:black;mso-ansi-language:ES">Gel de agarosa al 1% </SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black">1X TAE Buffer</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black">Lane 1: 100 <SPAN class="SpellE">pb</SPAN>
DNA ladder</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black">Lane 2: Purified ELP550</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black">Lane 3: No sample</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black">Lane 3: Unpurified ELP550</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:
150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;color:black"><O:P> </O:P></SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Domestication with overhang PCR of <SPAN class="SpellE">bsCcPax</SPAN>.
<B style="mso-bidi-font-weight:normal">Participation:</B> Natalia Torres in
collaboration with Eduardo <SPAN class="SpellE">Moncayo</SPAN>.</SPAN></P><P class="MsoNormal" style="margin-left:35.4pt;text-align:justify;line-height:
150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:
&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">In the electrophoresis gel
(1% agarose) with 1 kb DNA ladder (Lane 1), we obtained unspecific bands (Lane
2-6). </SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Talks on the importance of synthetic biology in the world and
prospective in the country, in Unidad <SPAN class="SpellE">Educativa</SPAN>
Antares. <B style="mso-bidi-font-weight:normal">Participation:</B> Diego Garzon
and Natalia Torres, in collaboration with Francisco <SPAN class="SpellE">Mosquera</SPAN>.</SPAN></P><P class="MsoNormal" align="center" style="margin-left:35.4pt;text-align:center;
line-height:150%"> </P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">September - </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Week 44</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">In this week, we obtained the results of the sequence that was
sent to sequence.</SPAN></P><P class="MsoNormal" align="center" style="margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:.5in;margin-bottom:.0001pt;text-align:center;
text-indent:-.5in;line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US"><O:P> </O:P></SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:
150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Domestication with overhang PCR of <SPAN class="SpellE">bsCmCax</SPAN>
and <SPAN class="SpellE">bsCcPax</SPAN>. </SPAN></P><P class="MsoNormal" align="center" style="margin-left:35.4pt;text-align:center;
line-height:150%"> </P><P class="MsoNormal" style="margin-left:35.4pt;text-align:justify;line-height:
150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:
&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">In the electrophoresis gel
(1% agarose) with 1 kb DNA ladder (Lane 1), we obtained unspecific bands of <SPAN class="SpellE">bsCmCax</SPAN> (Lane 2) and expected band of <SPAN class="SpellE">bsCcPax</SPAN>
(Lane 3 - 1512 <SPAN class="SpellE">bp</SPAN>), but with low concentration. <B style="mso-bidi-font-weight:normal">Participation:</B> Natalia Torres in
collaboration with Eduardo <SPAN class="SpellE">Moncayo</SPAN>.</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">September - </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Week 45</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Domestication with overhang PCR of <SPAN class="SpellE">bscA</SPAN>,
<SPAN class="SpellE">bscB</SPAN> and <SPAN class="SpellE">bsCmCax</SPAN>. </SPAN></P><P class="MsoNormal" align="center" style="margin-left:35.4pt;text-align:center;
line-height:150%"> </P><P class="MsoNormal" style="margin-left:35.4pt;text-align:justify;line-height:
150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:
&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">In the electrophoresis gel
(1% agarose) with 1 kb DNA ladder (Lane 1), we obtained expected bands of <SPAN class="SpellE">bscA</SPAN> (Lane 2 - 2536 <SPAN class="SpellE">bp</SPAN>), <SPAN class="SpellE">bscB</SPAN> (Lane 3 - 2827 <SPAN class="SpellE">bp</SPAN>) and <SPAN class="SpellE">bsCmCax</SPAN> (Lane 4 - 1522 <SPAN class="SpellE">bp</SPAN>). <B style="mso-bidi-font-weight:normal">Participation:</B> Natalia Torres in
collaboration with Eduardo <SPAN class="SpellE">Moncayo</SPAN>.</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">September - </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Week 46</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">We prepare the shipment of our parts and send the plasmids
psb1c3-CBD cipA-BMP2 y psb1c3-CBD <SPAN class="SpellE">cipA-sfGFP</SPAN>. <B style="mso-bidi-font-weight:normal">Participation:</B> Camila <SPAN class="SpellE">Velandia</SPAN> in collaboration with Francisco <SPAN class="SpellE">Mosquera</SPAN>.</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l8 level1 lfo9;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Gibson assembly. <B style="mso-bidi-font-weight:normal">Participation:</B>
Nicolas Lopez in collaboration with Eduardo <SPAN class="SpellE">Moncayo</SPAN>.</SPAN></P><P class="MsoNormal" align="center" style="margin-left:35.4pt;text-align:center;
line-height:150%"> </P><P class="MsoNormal" style="margin-left:35.4pt;text-align:justify;line-height:
150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:
&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">In the electrophoresis gel
(1% agarose) with 1 kb DNA ladder (Lane 1), we obtained degraded DNA in another
Lanes. We faced with several problems that occurred during this trial and we
could not obtain the assembled vectors that we wanted. </SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">September - </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Week 47</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">We prepare the shipment of our parts and send the plasmids
psb1c3-CBD cipA-BMP2 y psb1c3-CBD <SPAN class="SpellE">cipA-sfGFP</SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">. <B style="mso-bidi-font-weight:normal"><SPAN style="color:black">Participation:</SPAN></B><SPAN style="color:black"><SPAN class="SpellE">Estefany</SPAN> Paredes and Camila <SPAN class="SpellE"><SPAN class="GramE">Velandia</SPAN></SPAN><SPAN class="GramE">,in</SPAN> collaboration with Francisco <SPAN class="SpellE">Mosquera</SPAN>.</SPAN></SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l1 level1 lfo5;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Extraction
of fusion protein CBD-<SPAN class="SpellE">sfGFP</SPAN> with </SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l8 level1 lfo9;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Domestication with overhang PCR of <SPAN class="SpellE">bsCcPax</SPAN>.
<B style="mso-bidi-font-weight:normal">Participation:</B> Nicolas Lopez</SPAN></P><P class="MsoNormal" align="center" style="margin-left:35.4pt;text-align:center;
line-height:150%"> </P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">In the electrophoresis gel (1% agarose) with 1
kb DNA ladder (Lane 1), we obtained expected band of <SPAN class="SpellE">bsCcPax</SPAN>
(Lane 2 - 1512 <SPAN class="SpellE">bp</SPAN>) with two tenuous unspecific bands.
</SPAN></P><P class="MsoNormal" style="margin-left:35.4pt;text-align:justify;line-height:
150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:
&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">October - </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Week 48</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l8 level1 lfo9"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">In
this week, we started with the characterization of the binding strength of the
CBD <SPAN class="SpellE">cipA</SPAN> with an endogenous C-terminal linker.
Through fluorescence measurement of: cellulose with GFP like negative control,
cellulose with the fusion protein CBD-<SPAN class="SpellE">sfGFP</SPAN> and the
last one, after three washes with <SPAN class="SpellE">differents</SPAN> fluids:
blood plasma, PBS, saliva and distilled water. <B style="mso-bidi-font-weight:
normal">Participation: </B>Natalia Torres and <SPAN class="SpellE">Estefany</SPAN>
Paredes, in collaboration with Francisco <SPAN class="SpellE">Mosquera</SPAN>.</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l8 level1 lfo9"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Gibson assembly.</SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial"> Using the Gibson assembly kit instructions from
NEB with DMSO, we obtained the same result of first Gibson assembly. We believe
that there are loops forming during the process. <B style="mso-bidi-font-weight:
normal">Participation:</B> Nicolas Lopez in collaboration with Eduardo <SPAN class="SpellE">Moncayo</SPAN>.</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l8 level1 lfo9"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial"><SPAN style="color:black">A third course of
molecular techniques was carried out. <B style="mso-bidi-font-weight:normal">Participation:</B>
Everyone</SPAN></SPAN></P><P class="MsoNormal" style="margin-left:.5in;text-align:justify;line-height:150%;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial;color:black"><O:P> </O:P></SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">October
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 49</SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;mso-add-space:auto;text-align:justify;
text-indent:-.25in;line-height:150%;mso-list:l8 level1 lfo9;border:none;
mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Finishing the wiki. <B style="mso-bidi-font-weight:normal">Participation:</B>
Everyone</SPAN></P><P class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.5in;
line-height:150%;border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;
mso-border-shadow:yes"><SPAN lang="EN-US"><O:P> </O:P></SPAN></P><P class="MsoNormalCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;
text-align:justify;text-indent:-.25in;line-height:150%;mso-list:l8 level1 lfo9;
border:none;mso-padding-alt:31.0pt 31.0pt 31.0pt 31.0pt;mso-border-shadow:yes"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Noto Sans Symbols&quot;;
mso-fareast-font-family:&quot;Noto Sans Symbols&quot;;mso-bidi-font-family:&quot;Noto Sans Symbols&quot;;
color:black"><SPAN style="mso-list:Ignore">●<SPAN style="font:7.0pt &quot;Times New Roman&quot;">     </SPAN></SPAN></SPAN><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial;
color:black">Celebration of Birthday of our PI Francisco Flores. Thanks for
everything!!!<B style="mso-bidi-font-weight:normal"> Participation: </B>Everyone.</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><B style="mso-bidi-font-weight:normal"><SPAN lang="EN-US" style="font-size:12.0pt;
line-height:150%;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">October
- </SPAN></B><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;
font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:Arial">Week 50</SPAN></P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial">Meeting with the Undersecretary of Natural
Heritage of the Ministry of the Environment. Presentation of the <SPAN class="SpellE">iGEM</SPAN> Ecuador Project to facilitate the understanding and
future linkage of Modern Biotechnology, in the creation of norms and public
policies. <B style="mso-bidi-font-weight:normal">Participation:</B> Diego
Garzon and Nicolas Lopez.</SPAN></P><P class="MsoNormal" align="center" style="text-align:center;line-height:150%"> </P><P class="MsoNormal" style="text-align:justify;line-height:150%"><SPAN lang="EN-US" style="font-size:12.0pt;line-height:150%;font-family:&quot;Arial&quot;,sans-serif;
mso-fareast-font-family:Arial"><O:P> </O:P></SPAN></P></DIV></DIV></DIV><DIV class="ecuador_footer"><DIV class="ecuador_footer_information_layout"><DIV class="ecuador_footer_information_container"><DIV class="ecuador_footer_information_title_container">
            SPONSORS
		</DIV></DIV><DIV class="ecuador_footer_information_container"><DIV class="ecuador_footer_information_title_container">
            FOLLOW US
            </DIV></DIV><DIV class="ecuador_footer_information_container"><DIV class="ecuador_footer_information_title_container">
            CONTACT US
			<DIV class="ecuador_information_data_container">
				biosin.espe@outlook.es
			UNIVERSIDAD DE LAS FUERZAS ARMADAS ESPE.
			Ecuador,Sangolquí, Av. General Rumiñahui s/n y Ambato
			</DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>